摘要
【目的】探讨腹膜透析(PD)在尿毒症患者血液透析(HD)后大量腹水中的应用价值。【方法】对25例HD后大量腹水的慢性肾衰患者,在给予内科综合治疗同时,先给予间歇性腹膜透析(IPD),1周后转为持续性不卧床腹膜透析(CAPD)。观察患者自觉症状及浮肿等体征的改善情况,测定透析方式改变前、治疗6个月后腹水生化,尿素氮(BUN)、血肌酐(Scr)、血红蛋白(Hb)、总蛋白(TP)、白蛋白(Alb)等指标的变化情况。【结果】患者经PD后自觉症状均明显好转,食欲改善,浮肿逐渐消退。患者透析后Scr、BUN明显下降,Hb、TP、Alb明显上升(P<0.01)。【结论】PD是治疗HD后大量腹水患者的一种有效手段,值得推广。
[Objective]To investigate the effect of peritoneal dialysis in the treatment of patients with mass ascites after hemodialysis. [Methods] Twenty five patients with mass ascites after hemodialysis received internal medicine therapy combined with intermittent peritoneal dialysis（IPD）, and then continuous ambulatory peritoneal dialysis（CAPD） after a week. The subjective symptom and edema were observed, and biochemistry of ascites, blood urea nitrogen（BUN ）, serum creatinine（Scr）, hemoglobin（Hb）, total protein（TP）, albumin （Alb） before changing modes of dialysis and 6 months after treatment were determined. [Results] After peritoneal dialysis, the subjective symptoms of all patients got better obviously, the appetite improved, the edema disappeared gradually, and Scr and BUN decreased obviously（ P 〈0.01）, while Hb, TP, Alb increased significantly（ P 〈0.01）. [Conclusion] Peritoneal dialysis is and effective treatment for patients with mass ascites after hemodialysis, thus it＇s worthy of clinical generalization.
出处
《医学临床研究》
CAS
2008年第7期1263-1264,1267,共3页
Journal of Clinical Research
